Patents by Inventor Andy Sturman

Andy Sturman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11913943
    Abstract: System and method embodiments for analyzing a test fluid to detect prior or present infestations of bed bugs are described. In an embodiment, the method may include receiving the test fluid on a test strip within the detection device. The test strip may include a reaction portion and a reagent portion containing an antibody or antigen-binding fragment that is conjugated to a colored particle. The test fluid may include bed bug antigen that reacts with the conjugated antibody. The detection device may include a first and a second optical sensor for monitoring a reaction and a background color intensity, respectively. Upon a predetermined time delay elapsing, the detection device determines whether bed bug antigen is present in the test fluid using the monitored color intensities and minimum and maximum color intensity thresholds associated with bed bugs. Then, the detection device outputs a result using a visual display.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: February 27, 2024
    Assignee: Redcoat Solutions, Inc.
    Inventors: William John Hall, Benedict Louis Zin, Andy Sturman, Min Wang
  • Publication number: 20240058617
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Application
    Filed: October 31, 2023
    Publication date: February 22, 2024
    Inventors: Andy STURMAN, David PICCO, Rory M. BEYER, Gordon Moseley P. ANDREWS, Dean Allan GEREAUX
  • Patent number: 11839770
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: December 12, 2023
    Assignee: Avive Solutions, Inc.
    Inventors: Andy Sturman, David Picco, Rory M. Beyer, Gordon Moseley P. Andrews, Dean Allan Gereaux
  • Patent number: 11534618
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward, received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the medical device, updating the medical device's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: December 27, 2022
    Assignee: Avive Solutions, Inc.
    Inventors: Andy Sturman, David Picco, Rory M. Beyer, Andrew Thomas Galkowski, Gordon Moseley P. Andrews, Dean Allan Gereaux
  • Publication number: 20220339454
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Application
    Filed: July 8, 2022
    Publication date: October 27, 2022
    Inventors: Andy STURMAN, David PICCO, Rory M. BEYER, Gordon Moseley P. ANDREWS, Dean Allan GEREAUX
  • Patent number: 11452881
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: September 27, 2022
    Assignee: Avive Solutions, Inc.
    Inventors: Andy Sturman, David Picco, Rory M. Beyer, Gordon Moseley P. Andrews, Dean Allan Gereaux
  • Publication number: 20220214284
    Abstract: Devices, systems, and kits for assaying a liquid sample include a reader and a test strip. The test strip may comprise a disposable cassette. The system may include a test strip mounting structure configured to receive the cassette in a predetermined orientation. The apparatus includes a processor and memory, together configured to conduct an assay of the liquid sample. The apparatus may include a display configured to generate a pattern encoding data related to a result of the assay.
    Type: Application
    Filed: November 12, 2021
    Publication date: July 7, 2022
    Inventors: William John HALL, Andy STURMAN
  • Publication number: 20210316152
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward, received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the medical device, updating the medical device's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Application
    Filed: June 24, 2021
    Publication date: October 14, 2021
    Inventors: Andy STURMAN, David PICCO, Rory M. BEYER, Andrew Thomas GALKOWSKI, Gordon Moseley P. ANDREWS, Dean Allan GEREAUX
  • Patent number: 11077312
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: August 3, 2021
    Assignee: Avive Solutions, Inc.
    Inventors: Andy Sturman, David Picco, Rory M. Beyer, Andrew Thomas Galkowski, Gordon Moseley P. Andrews, Dean Allan Gereaux
  • Patent number: 11047844
    Abstract: An improved electronic diagnostic device for detecting the presence of an analyte in a fluid sample comprises a casing having a display, a test strip mounted in the casing, a processor mounted in the casing, and a first sensor mounted in the casing and operatively coupled to the processor. The processor is configured to receive a signal from the first sensor when the device is exposed to ambient light thereby causing the device to become activated. The device includes a light shield that exerts pressure across a width of the test strip to prevent fluid channeling along the length of the test strip. The processor is configured to present an early positive test result reading when a measured value exceeds a predetermined early reading threshold value at any time after a predetermined early testing time period.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: June 29, 2021
    Assignee: Church & Dwight Co., Inc.
    Inventors: Andy Sturman, Benedict Zin, Albert Nazareth, Henry Bell
  • Publication number: 20200378959
    Abstract: System and method embodiments for analyzing a test fluid to detect prior or present infestations of bed bugs are described. In an embodiment, the method may include receiving the test fluid on a test strip within the detection device. The test strip may include a reaction portion and a reagent portion containing an antibody or antigen-binding fragment that is conjugated to a colored particle. The test fluid may include bed bug antigen that reacts with the conjugated antibody. The detection device may include a first and a second optical sensor for monitoring a reaction and a background color intensity, respectively. Upon a predetermined time delay elapsing, the detection device determines whether bed bug antigen is present in the test fluid using the monitored color intensities and minimum and maximum color intensity thresholds associated with bed bugs. Then, the detection device outputs a result using a visual display.
    Type: Application
    Filed: August 14, 2020
    Publication date: December 3, 2020
    Inventors: William John HALL, Benedict Louis ZIN, Andy STURMAN, Min WANG
  • Patent number: 10823726
    Abstract: System and method embodiments for analyzing a test fluid to detect prior or present infestations of bed bugs are described. In an embodiment, the method may include receiving the test fluid on a test strip within the detection device. The test strip may include a reaction portion and a reagent portion containing an antibody or antigen-binding fragment that is conjugated to a colored particle. The test fluid may include bed bug antigen that reacts with the conjugated antibody. The detection device may include a first and a second optical sensor for monitoring a reaction and a background color intensity, respectively. Upon a predetermined time delay elapsing, the detection device determines whether bed bug antigen is present in the test fluid using the monitored color intensities and minimum and maximum color intensity thresholds associated with bed bugs. Then, the detection device outputs a result using a visual display.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: November 3, 2020
    Assignee: Redcoat Solutions, Inc.
    Inventors: William John Hall, Benedict Louis Zin, Andy Sturman, Min Wang
  • Publication number: 20200221263
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Application
    Filed: January 3, 2020
    Publication date: July 9, 2020
    Inventors: Andy STURMAN, David PICCO, Rory M. BEYER, Andrew Thomas GALKOWSKI, Gordon Moseley P. ANDREWS, Dean Allan GEREAUX
  • Publication number: 20200215346
    Abstract: Status messages are wirelessly broadcast from medical devices (e.g., defibrillators) as advertisements that don't require the establishment of a wireless connection with listeners. The listeners are configured to act on, or forward received status messages as appropriate. The listeners may optionally include supplemental information supplied by the listener device when forwarding a status message to a management server. The listener may optionally analyze received status messages to determine whether an action should be taken based at least in part on status information in the message. Actions performed by the listener may include initiating a connection with the transmitting device to facilitate uploading new information from the defibrillator, updating the defibrillator's firmware, etc. Optionally, some of the advertisements are configured as beacons. The advertisements/beacons may be transmitted using a Bluetooth Low Energy or other suitable protocols.
    Type: Application
    Filed: January 3, 2020
    Publication date: July 9, 2020
    Inventors: Andy STURMAN, David PICCO, Rory M. BEYER, Gordon Moseley P. ANDREWS, Dean Allan GEREAUX
  • Patent number: 10681516
    Abstract: Electronic test devices and methods include data transfer capabilities. In one implementation, an assay device includes wireless communication capabilities to send assay result decisions and/or values to a separate processing and display device such as a smartphone. In another implementation, light sources are modulated both for performing an assay and encoding and transmitting a result of an assay.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: June 9, 2020
    Assignee: Z-INTEGRATED DIGITAL TECHNOLOGIES, INC.
    Inventors: Benedict L. Zin, Andy Sturman, Albert R. Nazareth
  • Patent number: 10670533
    Abstract: Systems, methods, and test kits for monitoring and detecting variation in an analyte level in a fluid sample from an individual variation using a uniquely determined analyte threshold value. In one implementation, luteinizing hormone is the monitored analyte and is compared with the determined threshold value to predict the onset of ovulation for the individual.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: June 2, 2020
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert R. Nazareth, Andy Sturman, Benedict L. Zin, Henry Bell, Yea-Shun Cheng, Shang Li
  • Patent number: 10352946
    Abstract: An improved qualitative or semi-quantitative diagnostic test for low levels of any analyte, such as hCG, in a biological sample, such as urine. The test comprises of a test device containing reagents for the detection of the monitored analyte and an electronic reader that measures color development at a detection area of the device. The color development is converted to an electronic or digital signal. Improvements were made to the detection process to optimize the detection of a valid fluid front, increase the detection limit without compromising the reliability and accuracy of the test system, and improve the determination of test result validity.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: July 16, 2019
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert R. Nazareth, Andy Sturman, Benedict Zin
  • Patent number: 10101342
    Abstract: An improved qualitative or semi-quantitative diagnostic test for measuring low levels of any analyte, such as hCG, in a biological sample, such as urine. The test comprises a test device containing reagents for the detection of the monitored analyte and an electronic reader that measures color development at a detection area of the device. The color development is converted to an electronic or digital signal. Improvements were made to the electronic reader to optimize the coverage of the detection area on the test strip. This improves the detection sensitivity and consistency of the test result while maintaining its reliability and accuracy.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: October 16, 2018
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert R. Nazareth, Benedict Zin, Andy Sturman, Shang Li
  • Publication number: 20180259500
    Abstract: An improved electronic diagnostic device for detecting the presence of an analyte in a fluid sample comprises a casing having a display, a test strip mounted in the casing, a processor mounted in the casing, and a first sensor mounted in the casing and operatively coupled to the processor. The processor is configured to receive a signal from the first sensor when the device is exposed to ambient light thereby causing the device to become activated. The device includes a light shield that exerts pressure across a width of the test strip to prevent fluid channeling along the length of the test strip. The processor is configured to present an early positive test result reading when a measured value exceeds a predetermined early reading threshold value at any time after a predetermined early testing time period.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Applicant: Church & Dwight, Co., Inc.
    Inventors: Andy Sturman, Benedict Zin, Albert Nazareth, Henry Bell
  • Publication number: 20180209913
    Abstract: Systems, methods, and test kits for monitoring and detecting variation in an analyte level in a fluid sample from an individual variation using a uniquely determined analyte threshold value. In one implementation, luteinizing hormone is the monitored analyte and is compared with the determined threshold value to predict the onset of ovulation for the individual.
    Type: Application
    Filed: March 21, 2018
    Publication date: July 26, 2018
    Inventors: Albert R. Nazareth, Andy Sturman, Benedict L. Zin, Yea-Shun Cheng, Henry Bell, Shang Li